Edition:
United Kingdom

Edge Therapeutics Inc (EDGE.OQ)

EDGE.OQ on NASDAQ Stock Exchange Global Select Market

0.81USD
18 Oct 2018
Change (% chg)

-- (--)
Prev Close
$0.81
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
61,422
52-wk High
$17.76
52-wk Low
$0.70

Chart for

About

Edge Therapeutics, Inc. is a clinical-stage biotechnology company that discovers, develops and seeks to commercialize hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening critical care conditions. The Company's initial product candidates target rare, acute, life-threat... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $340.91
Shares Outstanding(Mil.): 30.85
Dividend: --
Yield (%): --

Financials

  EDGE.OQ Industry Sector
P/E (TTM): -- 85.41 33.64
EPS (TTM): -1.57 -- --
ROI: -43.75 0.21 14.27
ROE: -48.11 1.17 15.99

BRIEF-Edge Therapeutics Reports Quarterly Loss Per Share $0.67

* EDGE THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

01 May 2018

BRIEF-Edge Therapeutics Announces Review Of Strategic Alternatives

* EDGE THERAPEUTICS ANNOUNCES REVIEW OF STRATEGIC ALTERNATIVES

30 Apr 2018

Earnings vs. Estimates